There is a skin allergy epidemic in the western world, and the rate of deterioration has
increased significantly in the past 5–10 years. It is probable that there are many …

Nanomedicine strategies were first adapted and successfully translated to clinical
application for diseases, such as cancer and diabetes. These strategies would no doubt …

Cutaneous leishmaniasis causes alterations in the skin microbiota, leading to pathologic
immune responses and delayed healing. However, it is not known how these microbiota …

Skin microbiota can impact allergic and autoimmune responses, wound healing, and anti-
microbial defense. We investigated the role of skin microbiota in cutaneous leishmaniasis …

As described in previous work, the use of synthetic chemical ingredients in modern
cosmetics is postulated to be a cause of damage to the skin microbiome. The discovery that …

There has been a catastrophic loss of biodiversity in ecosystems across the world. A similar
crisis has been observed in the human gut microbiome, which has been linked to “all human …

Innate lymphoid cells (ILCs) comprise a heterogeneous population of immune cells that
maintain barrier function and can initiate a protective or pathological immune response upon …

Leishmaniasis is a vector-borne infectious disease caused by different species of protozoa
from the Leishmania genus. Classically, the disease can be classified into two main clinical …

The endemic strain of Leishmania donovani in Sri Lanka causes cutaneous leishmaniasis
(CL) rather than more common visceral form. We have visualized biofilms and profiled the …

Ethnopharmacological relevance Leishmaniasis are widely distributed among tropical and
subtropical countries, and remains a crucial health issue in Amazonia. Indigenous groups …